公开(公告)号：US20240189381A1

公开(公告)日：2024-06-13

申请号：US18518089

申请日：2023-11-22

Applicant: ZHEJIANG CHINESE MEDICAL UNIVERSITY

Inventor： Xuhong JIANG ,  Senlin SHI ,  Jingbo XU ,  Shanshan LU ,  Lingtian WENG ,  Yuqin LOU

IPC: A61K36/718 ,  A61K35/64 ,  A61K36/284 ,  A61K36/428 ,  A61K36/537 ,  A61K36/734 ,  A61K36/808 ,  A61K36/899 ,  A61P3/10

CPC classification number: A61K36/718 ,  A61K35/64 ,  A61K36/284 ,  A61K36/428 ,  A61K36/537 ,  A61K36/734 ,  A61K36/808 ,  A61K36/899 ,  A61P3/10 ,  A61K2236/15 ,  A61K2236/17 ,  A61K2236/39

Abstract: The present disclosure provides a traditional Chinese medicine (TCM) composition for preventing and treating diabetes, a TCM preparation and use thereof, and belongs to the technical field of medicine. The TCM composition includes the following raw materials: 3-20 parts by weight of Rhizoma Coptidis, 9-24 parts by weight of Rhizoma Atractylodis, 6-24 parts by weight of Feculae Bombycis, 10-60 parts by weight of Stigma Maydis, 10-60 parts by weight of Radix Trichosanthis, 6-30 parts by weight of Radix Scrophulariae, 10-60 parts by weight of Radix et Rhizoma Salviae Miltiorrhizae, and 10-50 parts by weight of Fructus Crataegi Preparata. In the TCM composition provided by the present disclosure, all medicinal materials are synergistic to achieve the effects of clearing heat, drying dampness, fortifying the spleen, dispersing blood stasis, dispersing accumulations, lowering lipids, nourishing yin and moistening dryness.

公开(公告)号：US20240041963A1

公开(公告)日：2024-02-08

申请号：US18258642

申请日：2021-12-22

Applicant: DiaBliss Consumer Products Pvt Ltd

Inventor： Vr. RAMANATHAN ,  Siva VALLABHANENI ,  V. RAJALAKSHMI

IPC: A61K36/39 ,  A61K36/428 ,  A61K36/28 ,  A61K36/75 ,  A61K36/736 ,  A61K36/52 ,  A61K36/48 ,  A61P17/14

CPC classification number: A61K36/39 ,  A61K36/428 ,  A61K36/28 ,  A61K36/75 ,  A61K36/736 ,  A61K36/52 ,  A61K36/48 ,  A61P17/14

Abstract: Nutraceutical formulations, which could be used for scalp and hair care purposes, with enhanced organoleptie properties have elements of biological origin more particularly a herbal formulation(s).

公开(公告)号：US10987389B2

公开(公告)日：2021-04-27

申请号：US15308831

申请日：2015-04-10

Applicant: Xingyao Li ,  Yeming Li

Inventor： Xingyao Li ,  Yeming Li

IPC: A61K36/07 ,  A61K36/8945 ,  A61K36/8964 ,  A61K36/899 ,  A61K35/36 ,  A61K36/02 ,  A61K36/06 ,  A61K36/074 ,  A61K36/232 ,  A61K36/236 ,  A61K36/35 ,  A61K36/428 ,  A61K35/64 ,  A61K35/618 ,  A61K36/487 ,  A61K36/536 ,  A61K36/539 ,  A61K36/708 ,  A61K36/74 ,  A61K36/03 ,  A61K36/355 ,  A61K36/69 ,  A61K36/748 ,  A61K36/8994

Abstract: An anti-tumor traditional Chinese medicine, a preparation method therefor, and uses thereof. This traditional Chinese medicine is prepared by leavening of Pleurotus sp. and Dioscorea bulbifera, pangolin scales, rhubarb, oyster, stiff silkworm, kelp, selfheal, Ligusticum wallichii, barbat skullcap, honeysuckle flower, Oldenlandia diffusa, Radix trichosanthis, Rhizoma anemarrhenae Scutellaria baicalensis, Angelica sinensis, Psoralea corylifolia, Lucid ganoderma, and coix seed.

公开(公告)号：US10646525B2

公开(公告)日：2020-05-12

申请号：US16233896

申请日：2018-12-27

Applicant: Muniyal Ayurvedic Research Centre

Inventor： M Vijayabhanu Shetty

IPC: A61K36/185 ,  A61P31/04 ,  A61K36/328 ,  A61K36/58 ,  A61K36/9066 ,  A61K33/04 ,  A61K33/26 ,  A61K33/34 ,  A61K33/22 ,  A61K35/618 ,  A61K45/06 ,  A61K36/67 ,  A61K36/24 ,  A61K36/882 ,  A61K36/9068 ,  A61K36/81 ,  A61K36/748 ,  A61K36/428 ,  A61K36/51 ,  A61K36/59 ,  A61K36/8905 ,  A61K36/68 ,  A61K36/9062 ,  A61K36/484 ,  A61P31/10

Abstract: Herbal composition for treatment and management of Infectious diseases and method of preparation are disclosed herein. The disclosed composition including herbs and bhasmas may be used to treat Infectious diseases such as bacterial infection, fungal infection, viral infections, Pharyngitis, Laryngitis and Bronchitis etc. The method disclosed herein may be used as the main line of treatment or as supportive medication.

公开(公告)号：US20180161386A1

公开(公告)日：2018-06-14

申请号：US15580652

申请日：2016-06-03

Applicant: THISHERB HEALTH PTY LTD

Inventor： Luping YU ,  Wencheng WANG

IPC: A61K36/54 ,  A61K36/9068 ,  A61K36/79 ,  A61K36/725 ,  A61K36/344 ,  A61K36/8945 ,  A61K36/28 ,  A61K36/899 ,  A61K36/428 ,  A61K36/704 ,  A61K36/8968 ,  A61K36/64 ,  A61K36/71 ,  A61K36/744 ,  A61K36/482 ,  A61P25/24

CPC classification number: A61K36/54 ,  A61K36/28 ,  A61K36/344 ,  A61K36/428 ,  A61K36/482 ,  A61K36/57 ,  A61K36/64 ,  A61K36/704 ,  A61K36/71 ,  A61K36/725 ,  A61K36/744 ,  A61K36/79 ,  A61K36/804 ,  A61K36/8945 ,  A61K36/8968 ,  A61K36/899 ,  A61K36/9068 ,  A61P25/24 ,  A61K2300/00

Abstract: Disclosed is a pharmaceutical composition for the treatment of Depression, wherein the pharmaceutical composition is comprised of the following herbs in weight parts: 2-10 parts Ramulus Cinnamomi, 2-10 parts Rhizoma Zingiberis, 2-10 parts Fructus Schisandrae Chinensis, 2-8 parts Semen Ziziphi Spinosae, 2-8 parts Radix Codonopsis, 1-3 parts Rhizoma Dioscoreae, 0.5-2.5 parts Flos Inulae, 1-3 parts Caulis Bambusae in Taenia, 1-3 parts Fructus Trichosanthis, 1.5-4 parts Caulis Polygoni Multiflori, 1.5-4 parts Radix Ophiopogonis, 2-8 parts Radix Rehmanniae, 1.5-4 parts Cortex Moutan Radicis, 0.5-2.5 parts Fructus Gardeniae, 0.5-2.5 parts Herba Lophatheri, and 0.2-1.5 parts Folium Sennae. Also disclosed is a method for preparing the pharmaceutical composition as described above for treatment of depression.

公开(公告)号：US20170128514A1

公开(公告)日：2017-05-11

申请号：US15409562

申请日：2017-01-19

Applicant: Zhizheng DU ,  Aftermath TAO

Inventor： Zhizheng DU ,  Aftermath TAO

IPC: A61K36/77 ,  A61K36/16 ,  A61K36/725 ,  A61K36/428 ,  A61K36/344 ,  A61K36/258 ,  A61K36/481 ,  A61K38/36 ,  A61K31/122 ,  A61K31/7034 ,  A61K36/736 ,  A61K31/343 ,  A61K36/236 ,  A61K31/36 ,  A61K9/20 ,  A61K36/18 ,  A61K31/366

CPC classification number: A61K36/77 ,  A61K9/20 ,  A61K9/2059 ,  A61K31/12 ,  A61K31/122 ,  A61K31/343 ,  A61K31/36 ,  A61K31/366 ,  A61K31/7034 ,  A61K35/56 ,  A61K36/16 ,  A61K36/18 ,  A61K36/185 ,  A61K36/236 ,  A61K36/258 ,  A61K36/344 ,  A61K36/428 ,  A61K36/481 ,  A61K36/537 ,  A61K36/725 ,  A61K36/73 ,  A61K36/736 ,  A61K36/8988 ,  A61K38/36

Abstract: A pharmaceutical composition, including, parts by weight of: 100-170 of a ginkgo flavone, 40-100 of a jujube extract, 100-200 of an extract of a peel of Trichosanthes kirilowii, 30-60 of a saponin of Codonopsis, 50-100 of a saponin of American ginseng, 40-70 of a saponin of Radix astragalu, 20-50 of hirudin, 3-10 of a coenzyme Q10, 40-100 of a longan extract, 20-50 of a modified starch, 100-150 of a carthamin, 100-150 of an extract of peach kernel, 30-50 of a gastordin, 120-200 of a salvianolic acid, 40-90 of an extract of Ligusticum chuanxiong, 100-150 of a saponin of Panax notoginseng, 0-50 of a black sesamin, and 0-50 of an astaxanthin.

公开(公告)号：US20220031791A1

公开(公告)日：2022-02-03

申请号：US17274968

申请日：2019-09-17

Applicant: Hong LI ,  JIANGSU JIUXU HAITIAN PHARMACEUTICAL CO., LTD.

Inventor： Ximing LIU ,  Hong LI

IPC: A61K36/718 ,  A61K36/062 ,  A61K36/428 ,  A61K36/54 ,  A61K36/752 ,  A61K36/8888 ,  A61P3/10 ,  A61K31/4375 ,  A61K31/7048 ,  A61K31/366

Abstract: Disclosed are a traditional Chinese medicine composition and a traditional Chinese medicine extract composition for treating metabolic syndrome. The traditional Chinese medicine composition consists of the following raw materials in the following weight ratio: 5-80% of Coptidis Rhizoma, 5-70% of Aurantii Fructus Immaturus, 0-60% of Pinelliae Rhizoma, 0-40% of Trichosanthis Fructus, 0-12% of Cinnamomi Cortex, and 10-60% of red yeast rice. The traditional Chinese medicine extract composition consists of the following raw materials in the following weight ratio: 2-30% of Coptidis Rhizoma extract, and 70-98% of a mixed extract from five traditional Chinese medicines comprising Aurantii Fructus Immaturus, Pinelliae Rhizoma, red yeast rice, Trichosanthis Fructus, and Cinnamomi Cortex. The traditional Chinese medicine composition or the traditional Chinese medicine extract composition contains the following active ingredients (mg/g): 6-122 mg/g of total alkaloids, which comprises 4-89 mg/g of berberine, 30-315 mg/g of total flavonoids, which comprises 20-186 mg/g of neohesperidin: and 0.5-9 mg/g of lovastatin. Further provided are preparation methods and applications of the above compositions.

公开(公告)号：US20180169168A1

公开(公告)日：2018-06-21

申请号：US15882105

申请日：2018-01-29

Applicant: UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY

Inventor： Seong Gyu KO ,  Sung Gook CHO ,  Youn Kyoung CHOI ,  Hee Sun YIM

IPC: A61K36/481 ,  A23L33/105 ,  A61K36/258 ,  A61K36/232 ,  A61K36/428

CPC classification number: A61K36/481 ,  A23L33/105 ,  A23V2002/00 ,  A61K36/232 ,  A61K36/258 ,  A61K36/428 ,  A61K2300/00

Abstract: The present invention relates to a composition containing, as an active ingredient, a mixed extract of Astragalus membranaceus, Angelica gigas, and Trichosanthes kirilowii, for preventing or treating cancer. The mixed extract of Astragalus membranaceus, Angelica gigas, and Trichosanthes kirilowii according to the present invention does not impact normal cell growth, while having an anticancer effect which specifically inhibits the proliferation of cancer cells, and an excellent effect of inhibiting metastasis of cancer cells, and thus can be useful in preventing or treating cancer and supplementing cancer treatment.

公开(公告)号：US09775870B2

公开(公告)日：2017-10-03

申请号：US15093089

申请日：2016-04-07

Applicant: AMOREPACIFIC CORPORATION

Inventor： Jun Seong Park ,  Hye Yoon Park ,  Dong Hyun Kim ,  Eun Jeong Moon ,  Ji Hye Chung ,  Jae Kyoung Lee ,  Duck Hee Kim ,  Han Kon Kim

IPC: A61K36/00 ,  A61K36/185 ,  A61K36/28 ,  A61K36/287 ,  A61K36/428 ,  A61K36/232 ,  A61K36/45 ,  A61K36/732 ,  A61K36/8945 ,  A61K36/78 ,  A23L33/105

CPC classification number: A61K36/185 ,  A23L33/105 ,  A23V2002/00 ,  A61K36/232 ,  A61K36/28 ,  A61K36/287 ,  A61K36/428 ,  A61K36/45 ,  A61K36/732 ,  A61K36/78 ,  A61K36/8945

Abstract: The present invention relates to an extract of a processed herbal medicinal plant and a composition for skin external application which contains the extract. More specifically, the composition for skin external application contains an extract of processed herbal medicinal plant, prepared through a method comprising the steps of: (a) processing an herbal medicinal plant by a process of boiling, steaming, roasting, baking or heating the medicinal plant or a combination of two or more of these processes; (b) obtaining an extract of the processed medicinal plant. The composition shows an improved antioxidant effect.

公开(公告)号：US20160243180A1

公开(公告)日：2016-08-25

申请号：US14897376

申请日：2014-06-11

Applicant: UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY

Inventor： Seong Gyu KO ,  Sung Gook CHO ,  Youn Kyoung CHOI ,  Hee Sun YIM

IPC: A61K36/481 ,  A61K36/428 ,  A61K36/258 ,  A61K36/232

CPC classification number: A61K36/481 ,  A23L33/105 ,  A23V2002/00 ,  A61K36/232 ,  A61K36/258 ,  A61K36/428 ,  A61K2300/00

Abstract: An embodiments of the invention relates to a composition containing, as an active ingredient, a mixed extract of Astragalus membranaceus, Angelica gigas, and Trichosanthes kirilowii, for preventing or treating cancer. The mixed extract of Astragalus membranaceus, Angelica gigas, and Trichosanthes kirilowii according to this embodiment of the invention does not impact normal cell growth, while having an anticancer effect which specifically inhibits the proliferation of cancer cells, and an excellent effect of inhibiting metastasis of cancer cells, and thus can be useful in preventing or treating cancer and supplementing cancer treatment.

Abstract translation: 本发明的一个实施方案涉及含有作为活性成分的黄芪混合提取物，当归和三叶草的组合物，用于预防或治疗癌症。 根据本发明的该实施方案的黄芪混合提取物，当归和三叶草不会影响正常的细胞生长，同时具有特异性抑制癌细胞增殖的抗癌作用，抑制癌转移的优异效果 细胞，因此可用于预防或治疗癌症并补充癌症治疗。